NCT02182687 2024-03-05
SBRTvsTACE
Lahey Clinic
Phase 2 Completed
Clinical Trials
28 trialsNCT01004978 2024-01-03
Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
National Cancer Institute (NCI)
Phase 3 Completed
NCT05291338 2023-07-28
Pharmacogenetic Study in Hepatocellular Carcinoma Patients.
Damanhour University
Completed
NCT00003907 2023-07-05
Chemoembolization in Treating Patients With Primary Liver Cancer or Metastases to the Liver
Eastern Cooperative Oncology Group
Phase 2 Completed
NCT00956930 2022-11-21
Chemoembolization Versus Radioembolization in Treating Patients With Liver Cancer That Cannot Be Treated With Radiofrequency Ablation Or Surgery
Northwestern University
Phase 2 Completed
NCT01015833 2022-08-04
Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT03604653 2022-08-03
Trial of Cytoreductive Surgery and HIPEC in Patients With Primary and Secondary Peritoneal Cancers
Holy Name Medical Center, Inc.
Completed
NCT01854255 2022-07-08
PIPAC-GA01
Ruhr University of Bochum
Phase 2 Completed
NCT01655693 2021-06-02
ReLive
Valerio Therapeutics
Phase 3 Completed
NCT01375699 2019-08-26
Doxorubicin With or Without Sildenafil, With Analysis of Cardiac Markers
Virginia Commonwealth University
Phase 1 Completed
NCT01011010 2018-01-05
Sorafenib Tosylate and Chemoembolization With Doxorubicin Hydrochloride and Mitomycin in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
UNC Lineberger Comprehensive Cancer Center
Phase 1 Completed
NCT00047229 2017-11-08
Oblimersen and Doxorubicin in Treating Patients With Advanced Hepatocellular Carcinoma (Liver Cancer)
University Health Network, Toronto
Phase 2 Completed
NCT00877071 2016-03-11
HCC
University of Pittsburgh
Phase 2 Completed
NCT00108953 2014-10-31
A Research Study to Treat Patients With Advanced Hepatocellular Carcinoma
Bayer
Phase 2 Completed
NCT00083226 2014-10-30
Doxorubicin and Bortezomib in Treating Patients With Liver Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT01116635 2014-03-17
Clinical Study Examining the Safety and Efficacy of Doxorubicin Drug Eluting Microspheres Transarterial Embolization in the Setting of Hepatocellular Carcinoma (HCC)
University of British Columbia
Phase 1/2 Completed
NCT00003912 2013-12-04
Chemotherapy in Treating Children With Liver Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00012324 2013-06-26
Nolatrexed Dihydrochloride Compared With Doxorubicin in Treating Patients With Recurrent or Unresectable Liver Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00003172 2013-06-21
Comparison of Combination Chemotherapy Regimens in Treating Patients With Advanced Stomach Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00098579 2013-03-19
Doxorubicin Hydrochloride and Alvocidib in Treating Patients With Metastatic or Recurrent Sarcoma That Cannot Be Removed By Surgery
National Cancer Institute (NCI)
Phase 1 Completed
NCT01042041 2013-02-26
Sorafenib Tosylate and Chemoembolization in Treating Patients With Unresectable Liver Cancer
Abramson Cancer Center at Penn Medicine
Phase 1 Completed
NCT00936689 2012-12-24
PRECISION-IT
University of Bologna
Phase 4 Completed
NCT00988195 2012-03-14
Study of Pegylated Human Recombinant Arginase for Liver Cancer
Bio-Cancer Treatment International Limited
Phase 1 Completed
NCT00003038 2011-08-03
Combination Chemotherapy With Suramin Plus Doxorubicin in Treating Patients With Advanced Solid Tumors
Mayo Clinic
Phase 1 Completed
NCT00004248 2011-03-07
Doxorubicin and Interleukin-2 in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery
Roswell Park Cancer Institute
Phase 2 Completed
NCT00478374 2010-11-02
S-TACE
University of Bern
Phase 1 Completed
NCT00471965 2010-09-20
EACH
Sanofi
Phase 3 Completed
NCT00165191 2009-04-28
Doxorubicin, Cisplatin, 5-Fluorouracil in Patients With Advanced Adenocarcinoma of the Stomach or Esophagus
Dana-Farber Cancer Institute
Phase 2 Completed